geographic atrophy

Astellas CRL ‘clearly a positive’ for Apellis, says JPMorgan
Tip Ranks
Tue, 11/19/24 - 11:13 am
Astellas
Apellis
FDA
geographic atrophy
Izervay
Syfovre
Astellas doesn't see eye to eye with Europe on geographic atrophy drug Izervay
Fierce Pharma
Mon, 10/28/24 - 06:12 pm
Astellas
Izervay
Apellis
Syfovre
geographic atrophy
Europe
Boehringer and CDR-Life report data from geographic atrophy treatment trial
Clinical Trials Arena
Fri, 09/6/24 - 10:49 am
Boehinger Ingelheim
CDR-Life
clinical trials
geographic atrophy
BI 771716
Apellis cites current challenges with Syfovre launch but bright prospects in the long term
Fierce Pharma
Wed, 02/28/24 - 09:42 pm
Apellis Pharmaceuticals
drug launches
geographic atrophy
Syfovre
Astellas’ Izervay reduces GA lesion growth in Phase III trial
Clinical Trials Arena
Mon, 11/6/23 - 09:51 am
Astellas
Izervay
geographic atrophy
age-related macular degeneration
clinical trials
Iveric Bio Announces Positive 24-Month Topline Results from Phase 3 Study of Izervay for Geographic Atrophy
PR Newswire
Tue, 09/19/23 - 10:28 am
Astellas
clinical trials
Izervay
geographic atrophy
Novartis Drops Eye Disease Gene Therapy from $800M Gyroscope Acquisition
BioSpace
Mon, 09/11/23 - 12:28 pm
Novartis
GT005
gene therapy
geographic atrophy
Gyroscope Therapeutics
Iveric drug approved for type of vision loss as rival’s safety draws scrutiny
BioPharma Dive
Sun, 08/6/23 - 09:25 pm
Iveric Bio
geographic atrophy
FDA
Izervay
Astellas
Annexon finds more silver linings in failed eye disease trial ahead of talks with FDA
Fierce Biotech
Mon, 07/31/23 - 10:17 am
Annexon
clinical trials
geographic atrophy
ANX007
Go or no go? Biogen and Astellas head towards key PDUFAs
EP Vantage
Sat, 07/29/23 - 10:45 pm
FDA
Astellas
Zimura
Biogen
SAGE Therapeutics
zuranolone
major depressive disorder
postpartum depression
geographic atrophy
Experts flag eye inflammation reports tied to Apellis' geographic atrophy med Syfovre
Fierce Pharma
Tue, 07/18/23 - 11:23 am
Apellis Pharmaceuticals
Syfovre
geographic atrophy
side effects
Annexon reports topline results from Phase II trial of geographic atrophy therapy
Clinical Trials Arena
Thu, 05/25/23 - 08:25 pm
Annexon
clinical trials
ANX007
vision loss
geographic atrophy
Apellis reports strong start for new vision loss drug
BioPharma Dive
Mon, 05/8/23 - 10:05 am
Apellis Pharmaceuticals
Syfovre
geographic atrophy
Playing catch-up, Boehringer taps RetinAI for AI boost to eye disease R&D
Fierce Biotech
Fri, 04/21/23 - 10:14 am
Boehringer Ingelheim
RetinAI
artificial intelligence
geographic atrophy
R&D
FDA accepts Iveric Bio's NDA, grants priority review for GA drug
Endpoints
Tue, 02/21/23 - 10:12 am
Iveric Bio
FDA
geographic atrophy
Apellis Pharmaceuticals
avacincaptad pegol
FDA Approves Apellis' Syfovre as First Treatment for Geographic Atrophy
BioSpace
Mon, 02/20/23 - 12:22 pm
Apellis Pharmaceuticals
Syfovre
pegcetacoplan
FDA
geographic atrophy
Merck & Co. bails on NGM eye disease collab in wake of phase 2 fail
Fierce Biotech
Wed, 12/21/22 - 11:29 am
Merck
NGM Biopharmaceuticals
clinical trials
eye disease
NGM621
geographic atrophy
Genentech starts phase 2 trial to optimize delivery of eye disease cell therapy
Fierce Pharma
Mon, 11/28/22 - 07:41 pm
Genentech
geographic atrophy
clinical trials
OpRegen
cell therapy
Apellis Pharmaceuticals Surges On New Review Date For Eye-Disease Treatment
Investors Business Daily
Fri, 11/18/22 - 11:30 am
Apellis Pharmaceuticals
pegcetacoplan
eye disease
geographic atrophy
Roche Scraps Mid-Phase Programs in Hepatitis B, Geographic Atrophy
BioSpace
Tue, 10/18/22 - 10:01 pm
Roche
hepatitis B
geographic atrophy

Pages